Low intensity rTMS in adolescent mice affects visuomotor behaviour with no impact on visual topography.

Background: Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique used as a therapeutic and experimental tool. It is FDA-approved for treating major depressive disorder in adults and has an excellent safety profile. rTMS is less well characterised in children but was recently approved as an augmentative treatment in adolescents (15-21 years).